نتایج جستجو برای: hepatic steatosis

تعداد نتایج: 96632  

Journal: :Journal of gastroenterology and hepatology 2006
Sathish Kumar Natarajan Chundamannil E Eapen Anna B Pullimood Kunissery A Balasubramanian

BACKGROUND Hepatic microvesicular steatosis is a clinical manifestation seen in a number of liver diseases. Although the role of mitochondrial beta-oxidation in the development of the disease has been well studied, information on lipid peroxidative damage in liver subcellular organelles is scarce. The present study looked at oxidative stress in hepatic peroxisomes and microsomes in microvesicul...

2011
Hongmei Yan Mingfeng Xia Xinxia Chang Qiong Xu Hua Bian Mengsu Zeng Shengxiang Rao Xiuzhong Yao Yinfang Tu Weiping Jia Xin Gao

BACKGROUND AND AIMS Fibroblasts growth factor 21 (FGF21), a liver-secreted endocrine factor involved in regulating glucose and lipid metabolism, has been shown to be elevated in patients with non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the quantitative correlation between serum FGF21 level and hepatic fat content. METHODS A total of 138 subjects (72 male and 66 fem...

2013
Di Wu Hongqi Li Guoan Xiang Liwei Zhang Lihong Li Yongmei Cao Jinqian Zhang

BACKGROUND HBV infection is a serious public health problem worldwide, which can contribute to the incidence of chronic hepatitis B (CHB), cirrhosis, and hepatocellular carcinoma (HCC). OBJECTIVES In the present report, we assessed the association between adiponectin, its receptors and hepatic steatosis, fibrosis, and inflammation with hepatitis B virus. PATIENTS AND METHODS Liver biopsies ...

2018
Bobby Guillory Nicole Jawanmardi Polina Iakova Barbara Anderson Pu Zang Nikolai A. Timchenko Jose M. Garcia

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. NAFLD usually begins as low-grade hepatic steatosis which further progresses in an age-dependent manner to nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma in some patients. Ghrelin is a hormone known to promote adiposity in rodents and humans, but its potential role in hep...

Journal: :iranian journal of veterinary medicine 2013
marjan chahardahcherik ali shahriari peyman asadian saleh esmaeilzadeh

background: hepatic steatosis due to estrogen therapyincreases the activity of inflammatory markers, particularly theactivity of tnfα which in turn induces more lipogenesis.omega-3 fatty acids are among the negative regulators of hepaticlipogenesis. objectives: in this research, the preventive effectof omega-3 fatty acids on estrogen-induced steatosis in rats wasevaluated. methods:2 mg/kg. bw/s...

Journal: :Clinical laboratory 2010
Esmat Ashour Nervana Samy Magda Sayed Azza Imam

BACKGROUND The mechanisms underlying steatosis during hepatitis C virus (HCV) infection are complex and multifactorial. The aim of our study was to assess whether host metabolic factors influence the degree of hepatic steatosis and fibrosis in patients infected with hepatitis C virus genotype 4 by investigating the role of adiponectin, leptin and insulin resistance. METHODS Adiponectin and le...

Journal: :The Journal of clinical investigation 2008
Catherine Postic Jean Girard

Nonalcoholic fatty liver disease (NAFLD) is associated with obesity, insulin resistance, and type 2 diabetes. NAFLD represents a large spectrum of diseases ranging from (i) fatty liver (hepatic steatosis); (ii) steatosis with inflammation and necrosis; and (iii) cirrhosis. Although the molecular mechanism leading to the development of hepatic steatosis in the pathogenesis of NAFLD is complex, r...

2011
Elizabeth K. Speliotes Laura M. Yerges-Armstrong Jun Wu Ruben Hernaez Lauren J. Kim Cameron D. Palmer Vilmundur Gudnason Gudny Eiriksdottir Melissa E. Garcia Lenore J. Launer Michael A. Nalls Jeanne M. Clark Braxton D. Mitchell Alan R. Shuldiner Johannah L. Butler Marta Tomas Udo Hoffmann Shih-Jen Hwang Joseph M. Massaro Christopher J. O'Donnell Dushyant V. Sahani Veikko Salomaa Eric E. Schadt Stephen M. Schwartz David S. Siscovick Benjamin F. Voight J. Jeffrey Carr Mary F. Feitosa Tamara B. Harris Caroline S. Fox Albert V. Smith W. H. Linda Kao Joel N. Hirschhorn Ingrid B. Borecki

Nonalcoholic fatty liver disease (NAFLD) clusters in families, but the only known common genetic variants influencing risk are near PNPLA3. We sought to identify additional genetic variants influencing NAFLD using genome-wide association (GWA) analysis of computed tomography (CT) measured hepatic steatosis, a non-invasive measure of NAFLD, in large population based samples. Using variance compo...

2015
Ken-ichiro Kato Yumie Takeshita Hirofumi Misu Yoh Zen Shuichi Kaneko Toshinari Takamura

AIMS/INTRODUCTION To examine the association between liver histological features and organ-specific insulin resistance indices calculated from 75-g oral glucose tolerance test data in patients with non-alcoholic fatty liver disease. MATERIALS AND METHODS Liver biopsy specimens were obtained from 72 patients with non-alcoholic fatty liver disease, and were scored for steatosis, grade and stage...

2016
Yu Zhang Ming Gu Wujie Cai Lijing Yu Li Feng Lu Zhang Qingqing Zang Yahui Wang Dongshan Wang Hui Chen Qingchun Tong Guang Ji Cheng Huang

Studies on peroxisome proliferator-activated receptor (PPAR)-γ ligands have been focused on agonists. However, PPARγ activation may induce obesity and nonalcoholic fatty liver disease (NAFLD), one of the most challenging medical conditions. Here, we identified that isorhamnetin, a naturally occurring compound in fruits and vegetables and the metabolite of quercetin, is a novel antagonist of PPA...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید